Dermatol. praxi. 2023;17(4):177-186 | DOI: 10.36290/der.2023.034

Bacterial skin infections I. - infections caused by gram-positive bacteria

doc. MUDr. Ondřej Kodet, Ph.D.
Dermatovenerologická klinika 1. LF UK a VFN, Praha
Anatomický ústav 1. LF UK, Praha

Cutaneous bacterial infections are one of the most common infectious in routine dermatological practice. Bacterial infections of the skin are divided according to the affected anatomical location or according to the causative pathogens. We most often encounter infections caused by streptococci, staphylococci and corynebacteria. In this first part, common and rarer manifestations of gram-positive bacteria are discussed, including diseases resulting from the production of bacterial toxins. Emphasis is placed on the clinical manifestation, diagnosis and antibiotic treatment.

Keywords: pyoderma, grampositive bacteria, Staphylococcus aureus, Streptococcus pyogenes, corynebacteria.

Accepted: November 15, 2023; Published: November 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kodet O. Bacterial skin infections I. - infections caused by gram-positive bacteria. Dermatol. praxi. 2023;17(4):177-186. doi: 10.36290/der.2023.034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aly R. Microbial Infections of Skin and Nails. Med Microbiol. 1996.
    2. Sadick NS. Current aspects of bacterial infections of the skin. Dermatol Clin. 1997;15(2):341-349. Go to original source... Go to PubMed...
    3. Osio A. [Corynebacterium-associated skin infections]. Ann Dermatol Venereol. 2018;145(3):214-218. Go to original source... Go to PubMed...
    4. Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5(5):301-310. Go to original source... Go to PubMed...
    5. Stout L, Stephens M, Hashmi F. Purulent Skin and Soft Tissue Infections, Challenging the Practice of Incision and Drainage: A Scoping Review. Newman C, editor. Nurs Res Pract. 2023;2023:5849141. Go to original source... Go to PubMed...
    6. Kotlářová A, Molitor M, Christodoulou P, et al. Antibiotic therapy in the treatment of skin abscess meta-analysis. Rozhl Chir. 2021;100(7):325-329. Go to original source... Go to PubMed...
    7. Gottlieb M, DeMott JM, Hallock M, et al. Systemic Antibiotics for the Treatment of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis. Ann Emerg Med. 2019;73(1):8-16. Go to original source... Go to PubMed...
    8. Kursawe Larsen C, Kjærsgaard Andersen R, Saunte DML, et al. Primary skin abscess microbiota a systematic review. APMIS. 2023;131(5):183-188. Go to original source... Go to PubMed...
    9. Microbial Infections of Skin and Nails - Medical Microbiology - NCBI Bookshelf 1996 [on-line]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8301/.
    10. Hartman-adams H, Banvard C, Juckett G. Impetigo: Diagnosis and Treatment. Am Fam Physician. 2014;90(4): 229-235.
    11. Brazel M, Desai A, Are A, et al. Staphylococcal Scalded Skin Syndrome and Bullous Impetigo. Medicina (Kaunas). 2021;57(11). Go to original source... Go to PubMed...
    12. Liy-Wong C, Pope E, Weinstein M, et al. Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38(1):149-153. Go to original source... Go to PubMed...
    13. Leung AKC, Barankin B, Leong KF. Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management. World J Pediatr. 2018;14(2):116-120. Go to original source... Go to PubMed...
    14. Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28(11):1418-1423. Go to original source... Go to PubMed...
    15. Wilkins AL, Steer AC, Smeesters PR, et al. Toxic shock syndrome - the seven Rs of management and treatment. J Infect. 2017;74 Suppl 1:S147-152. Go to original source... Go to PubMed...
    16. Gottlieb M, Long B, Koyfman A. The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department: A Review of the Literature. J Emerg Med. 2018;54(6):807-814. Go to original source... Go to PubMed...
    17. Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: Epidemiology, pathogenesis, and management. Pediatr Drugs. 2005;7(1):11-24. Go to original source... Go to PubMed...
    18. Managing scarlet fever. Drug Ther Bull. 2017;55(9):102. Go to original source... Go to PubMed...
    19. Vu MLD, Rajnik M. Arcanobacterium haemolyticum Infection. Princ Pract Pediatr Infect Dis Third Ed. 2023;751-752.
    20. Parks T, Wilson C, Curtis N, et al. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2018;67(9):1434. Go to original source... Go to PubMed...
    21. Bartoszko JJ, Elias Z, Rudziak P, et al. Prognostic factors for streptococcal toxic shock syndrome: systematic review and meta-analysis. BMJ Open. 2022;12(12). Go to original source... Go to PubMed...
    22. Martin JM, Green M. Group A Streptococcus. Semin Pediatr Infect Dis. 2006;17(3):140-148. Go to original source... Go to PubMed...
    23. Kelly C, Taplin D, Allen AM. Streptococcal ecthyma. Treatment with benzathine pencillin G. Arch Dermatol. 1971;103(3):306-310. Go to original source...
    24. Korte AKM, Vos JM. Ecthyma Gangrenosum. N Engl J Med. 2017;377(23):e32. Go to original source... Go to PubMed...
    25. Bonnetblanc JM, Bédane C. Erysipelas: recognition and management. Am J Clin Dermatol. 2003;4(3):157-163. Go to original source... Go to PubMed...
    26. Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008;2008.
    27. Clebak KT, Malone MA. Skin Infections. Prim Care - Clin Off Pract. 2018;45(3):433-454. Go to original source... Go to PubMed...
    28. Elizabeth B, Daniela K. Cellulitis: diagnosis and management. Dermatol Ther. 2011;24(2):229-239. Go to original source... Go to PubMed...
    29. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016;316(3):325-337. Go to original source... Go to PubMed...
    30. Agarwal V, Chauhan S, Gupta RK. Pyomyositis. Neuroimaging Clin N Am. 2011;21(4):975-983. Go to original source... Go to PubMed...
    31. Chen LL, Fasolka B, Treacy C. Necrotizing fasciitis: A comprehensive review. Nursing (Lond). 2020;50(9):34-40. Go to original source... Go to PubMed...
    32. Lancerotto L, Tocco I, Salmaso R, et al. Necrotizing fasciitis: classification, diagnosis, and management. J Trauma Acute Care Surg. 2012;72(3):560-566. Go to original source... Go to PubMed...
    33. Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1). Go to original source... Go to PubMed...
    34. Abd Rashid AH, Ramli R, Ibrahim S. Clostridium perfringens surgical site infection after osteotomy for knee deformity correction in a non-immunocompromised child. Surg Infect (Larchmt). 2014;15(5):656-658. Go to original source... Go to PubMed...
    35. Khanna N. Clindamycin-resistant Clostridium perfringens cellulitis. J Tissue Viability. 2008;17(3):95-97. Go to original source... Go to PubMed...
    36. Zisova L, Valchev V, Kasabov G. Erythrasma in athletes and football players. Wiener Medizinische Wochenschrift. 2021;171(1-2):24-28. Go to original source... Go to PubMed...
    37. Groves JB, Nassereddin A, Freeman AM. Erythrasma. Eur Handb Dermatological Treat Third Ed. 2023;285-286.
    38. Palaniappan V, Murthy AB, Karthikeyan K. Pitted keratolysis. Clin Exp Dermatol. 2023;48(9):978-983. Go to original source... Go to PubMed...
    39. Bonifaz A, Váquez-González D, Fierro L, et al. Trichomycosis (trichobacteriosis): clinical and microbiological experience with 56 cases. Int J Trichology. 2013;5(1):12-6. Go to original source... Go to PubMed...
    40. Moore LSP, Leslie A, Meltzer M, et al. Corynebacterium ulcerans cutaneous diphtheria. Lancet Infect Dis. 2015;15(9):1100-1107. Go to original source... Go to PubMed...
    41. Khan S, Khan B, Batool W, et al. Primary Cutaneous Actinomycosis: A Diagnostic Enigma. Cureus. 2023;15(4). Go to original source... Go to PubMed...
    42. Veraldi S, Girgenti V, Dassoni F, et al. Erysipeloid: a review. Clin Exp Dermatol. 2009;34(8):859-862. Go to original source... Go to PubMed...
    43. Godshall CE, Suh G, Lorber B. Cutaneous Listeriosis. J Clin Microbiol. 2013;51(11):3591. Go to original source... Go to PubMed...
    44. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health. 2010;3(3):98-105. Go to original source... Go to PubMed...
    45. Cybulski RJ, Sanz P, O'Brien AD. Anthrax vaccination strategies. Mol Aspects Med. 2009;30(6):490-502. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.